Literature DB >> 16228914

Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure.

I H Zucker1, J L Liu.   

Abstract

Activation of the sympathetic nervous system is a compensatory mechanism which initially provides support for the circulation in the face of a falling cardiac output. It has been recognized for some time that chronic elevation of sympathetic outflow with the consequent increase in plasma norepinephrine, is counterproductive to improving cardiac function. Indeed, therapeutic targeting to block excessive sympathetic activation in heart failure is becoming a more accepted modality. The mechanism(s) by which sympathetic excitation occurs in the heart failure state are not completely understood. Components of abnormal cardiovascular reflex regulation most likely contribute to this sympatho-excitation. However, central mechanisms which relate to the elaboration of angiotensin II (Ang II) and nitric oxide (NO) may also play an important role. Ang II has been shown to be a sympatho-excitatory peptide in the central nervous system while NO is sympatho-inhibitory. Recent studies have demonstrated that blockade of Ang II receptors of the AT(1) subtype augments arterial baroreflex control of sympathetic nerve activity in the heart failure state, thereby predisposing to a reduction in sympathetic tone. Ang II and NO interact to regulate sympathetic outflow. Blockade of NO production in normal conscious rabbits was only capable of increasing sympathetic outflow when accompanied by a background infusion of Ang II. Conversely, providing a source of NO to rabbits with heart failure reduced sympathetic nerve activity when accompanied by blockade of AT(1) receptors. Chronic heart failure is also associated with a decrease in NO synthesis in the brain as indicated by a reduction in the mRNA for the neuronal isoform (nNOS). Chronic blockade of Ang II receptors can up regulate nNOS expression. In addition, exercise training of rabbits with developing heart failure has been shown to reduce sympathetic tone, decrease plasma Ang II, improve arterial baroreflex function and increase nNOS expression in the central nervous system. This review summarizes a large number of studies which have concentrated on the mechanisms of sympatho-excitation in heart failure. It now seems clear that one mechanism which is important in regulating sympathetic outflow in this disease state depends upon a central interaction between Ang II and NO at the cellular and nuclear levels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 16228914     DOI: 10.1023/A:1009894007055

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  163 in total

Review 1.  Beta-adrenergic receptor regulation in the heart in pathophysiologic states: abnormal adrenergic responsiveness in cardiac disease.

Authors:  C J Homcy; S F Vatner; D E Vatner
Journal:  Annu Rev Physiol       Date:  1991       Impact factor: 19.318

2.  Daily exercise attenuates the sympathetic nerve response to exercise by enhancing cardiac afferents.

Authors:  S E DiCarlo; L K Stahl; V S Bishop
Journal:  Am J Physiol       Date:  1997-09

3.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

Review 4.  Role of AT1 receptors in the central control of sympathetic vasomotor function.

Authors:  G A Head
Journal:  Clin Exp Pharmacol Physiol       Date:  1996-09       Impact factor: 2.557

5.  Impaired chronotropic response to exercise in patients with congestive heart failure. Role of postsynaptic beta-adrenergic desensitization.

Authors:  W S Colucci; J P Ribeiro; M B Rocco; R J Quigg; M A Creager; J D Marsh; D F Gauthier; L H Hartley
Journal:  Circulation       Date:  1989-08       Impact factor: 29.690

6.  Heart failure depresses endothelium-dependent responses in canine femoral artery.

Authors:  L Kaiser; R C Spickard; N B Olivier
Journal:  Am J Physiol       Date:  1989-04

7.  Carotid baroreflex responsiveness during dynamic exercise in humans.

Authors:  J T Potts; X R Shi; P B Raven
Journal:  Am J Physiol       Date:  1993-12

8.  Endogenous nitric oxide modulates vasopressor responses, but not depressor responses, to spinal sympathetic nerve stimulation in pithed rats.

Authors:  M R MacLean; J Graham; J C McGrath
Journal:  J Cardiovasc Pharmacol       Date:  1994-02       Impact factor: 3.105

9.  Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.

Authors:  B Clemson; L Gaul; S S Gubin; D M Campsey; J McConville; J Nussberger; R Zelis
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

10.  Effects of L-arginine-derived nitric oxide synthesis on neuronal activity in nucleus tractus solitarius.

Authors:  S Ma; F M Abboud; R B Felder
Journal:  Am J Physiol       Date:  1995-02
View more
  13 in total

1.  Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity.

Authors:  Ding Zhao; Belinda H McCully; Virginia L Brooks
Journal:  J Pharmacol Exp Ther       Date:  2012-07-18       Impact factor: 4.030

Review 2.  Reactive oxygen species in the neuropathogenesis of hypertension.

Authors:  Jeffrey R Peterson; Ram V Sharma; Robin L Davisson
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

3.  Reduced expression and activation of voltage-gated sodium channels contributes to blunted baroreflex sensitivity in heart failure rats.

Authors:  Huiyin Tu; Libin Zhang; Thai P Tran; Robert L Muelleman; Yu-Long Li
Journal:  J Neurosci Res       Date:  2010-11-15       Impact factor: 4.164

4.  Abnormal baroreflex function is dissociated from central angiotensin II receptor expression in chronic heart failure.

Authors:  Mohammad Fahim; Lie Gao; Tarek M Mousa; Dongmei Liu; Kurtis G Cornish; Irving H Zucker
Journal:  Shock       Date:  2012-03       Impact factor: 3.454

5.  Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.

Authors:  Karla K V Haack; Lie Gao; Alicia M Schiller; Pamela L Curry; Peter R Pellegrino; Irving H Zucker
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

6.  Endogenous angiotensin II has fewer effects but neuronal nitric oxide synthase has excitatory effects on renal sympathetic nerve activity in salt-sensitive hypertension-induced heart failure.

Authors:  Takehito Kemuriyama; Megumi Tandai-Hiruma; Kazuo Kato; Hiroyuki Ohta; Satoshi Maruyama; Yoshiaki Sato; Yasuhiro Nishida
Journal:  J Physiol Sci       Date:  2009-03-28       Impact factor: 2.781

Review 7.  Nitric oxide regulation of autonomic function in heart failure.

Authors:  Harold D Schultz
Journal:  Curr Heart Fail Rep       Date:  2009-06

8.  Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure.

Authors:  Lie Gao; Yulong Li; Harold D Schultz; Wei-Zhong Wang; Wei Wang; Marcus Finch; Lynette M Smith; Irving H Zucker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-31       Impact factor: 4.733

9.  Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans.

Authors:  Colin N Young; James P Fisher; Kevin M Gallagher; Adam Whaley-Connell; Kunal Chaudhary; Ronald G Victor; Gail D Thomas; Paul J Fadel
Journal:  J Physiol       Date:  2009-09-01       Impact factor: 5.182

10.  Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy.

Authors:  Yumei Feng; Chetan Hans; Elizabeth McIlwain; Kurt J Varner; Eric Lazartigues
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.